Pyoderma gangrenosum and its impact on quality of life: a multicentre, prospective study
- 26 October 2018
- journal article
- letter
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 180 (3), 672-673
- https://doi.org/10.1111/bjd.17347
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort studyJournal of the American Academy of Dermatology, 2016
- Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trialBMJ, 2015
- Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patientsOrphanet Journal of Rare Diseases, 2013
- Diagnosis and management of parastomal pyoderma gangrenosumGastroenterology Report, 2013
- Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patientsBritish Journal of Dermatology, 2011
- Investigation of new co‐factors in 49 patients with pyoderma gangrenosumJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2011
- The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical resultsBritish Journal of Dermatology, 2008
- Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trialGut, 2006